Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reem Ali

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Molecular Biology Reports|December 11, 2019
Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in EgyptAmani Ahmed Alrehaili, Amal Fathi Gharib, Rehab Ahmed Karam, et al.
Therapeutic Advances in Medical Oncology|January 11, 2021
XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparibReem Ali, Adel Alblihy, Michael S Toss, et al.
Biomedicines|January 13, 2021
Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian CancersAdel Alblihy, Muslim L Alabdullah, Reem Ali, et al.
Nurse Education Today|June 12, 2025
Nursing students' test anxiety and academic self-efficacy, dishonesty and performance: A structural equation modelDaniel Joseph E Berdida, Rizal Angelo N Grande, Amr M Mohamed, et al.
Plos One|May 22, 2024
Loss of the yeast transporter Agp2 upregulates the pleiotropic drug-resistant pump Pdr5 and confers resistance to the protein synthesis inhibitor cycloheximideYusra Manzoor, Mustapha Aouida, Ramya Ramadoss, et al.
Cancer Letters|November 1, 2019
PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancersReem Ali, Muslim Alabdullah, Adel Alblihy, et al.
Oncotarget|May 19, 2025
PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signalingReem Ali, Mashael Algethami, Amera Sheha, et al.
Cells|December 9, 2023
Altered Regulation of the Glucose Transporter GLUT3 in PRDX1 Null Cells Caused Hypersensitivity to ArseniteReem Ali, Abdallah Alhaj Sulaiman, Bushra Memon, et al.
Breast Cancer Research and Treatment|August 18, 2021
The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS)Abdulbaqi Al-Kawaz, Reem Ali, Michael S Toss, et al.
Psychophysiology|September 11, 2025
It's About Time-Breathing Dynamics Modulate Emotion and CognitionJosh Goheen, Yasir Çatal, Imola MacPhee, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Molecular Biology Reports|December 11, 2019
Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in EgyptAmani Ahmed Alrehaili, Amal Fathi Gharib, Rehab Ahmed Karam, et al.
Therapeutic Advances in Medical Oncology|January 11, 2021
XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparibReem Ali, Adel Alblihy, Michael S Toss, et al.
Biomedicines|January 13, 2021
Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian CancersAdel Alblihy, Muslim L Alabdullah, Reem Ali, et al.
Nurse Education Today|June 12, 2025
Nursing students' test anxiety and academic self-efficacy, dishonesty and performance: A structural equation modelDaniel Joseph E Berdida, Rizal Angelo N Grande, Amr M Mohamed, et al.
Plos One|May 22, 2024
Loss of the yeast transporter Agp2 upregulates the pleiotropic drug-resistant pump Pdr5 and confers resistance to the protein synthesis inhibitor cycloheximideYusra Manzoor, Mustapha Aouida, Ramya Ramadoss, et al.
Cancer Letters|November 1, 2019
PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancersReem Ali, Muslim Alabdullah, Adel Alblihy, et al.
Oncotarget|May 19, 2025
PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signalingReem Ali, Mashael Algethami, Amera Sheha, et al.
Cells|December 9, 2023
Altered Regulation of the Glucose Transporter GLUT3 in PRDX1 Null Cells Caused Hypersensitivity to ArseniteReem Ali, Abdallah Alhaj Sulaiman, Bushra Memon, et al.
Breast Cancer Research and Treatment|August 18, 2021
The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS)Abdulbaqi Al-Kawaz, Reem Ali, Michael S Toss, et al.
Psychophysiology|September 11, 2025
It's About Time-Breathing Dynamics Modulate Emotion and CognitionJosh Goheen, Yasir Çatal, Imola MacPhee, et al.
Pageof 7